Subraxx 200 mg/2 ml (100 mg/ml) Solution for injection
PDF Leaflet Revision Date: 09 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Routine and immediate reversal of neuromuscular blockade induced by rocuronium or vecuronium.
Dosage (summary)
Adults: 4 mg/kg for routine reversal, 16 mg/kg for immediate reversal at 3 mins. Children (7+ years): 2 mg/kg.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Obese patients
Pregnancy & Breastfeeding
Safety in pregnancy not established; caution in breastfeeding due to unknown excretion in milk.
Key Drug Interactions
- Toremifene
- Fusidic acid
- Hormonal contraceptives
Contraindications
- Hypersensitivity to sugammadex or excipients
Common side effects
- Cough
- Dysgeusia
- Headache
- Marked bradycardia
Counselling Points
- Monitor for recurrence of neuromuscular blockade
- Ventilatory support may be required
- Inform about potential hypersensitivity reactions
Serious warnings
- Not for use with depolarising NMBA
- Risk of recurrence of neuromuscular blockade
- Marked bradycardia
Important Disclaimer
The Subraxx 200 mg/2 ml (100 mg/ml) Solution for injection professional information leaflet below is the property of Abex Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
